Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
49 studies found for:    Open Studies | "Keratosis, Actinic"
Show Display Options
Rank Status Study
1 Recruiting IM Versus 5-FU Versus IMI Versus MAL-PDT in Treatment of Actinic Keratosis
Condition: Keratosis, Actinic
Interventions: Drug: Imiquimod;   Drug: 5-fluorouracil;   Drug: Ingenol mebutate;   Procedure: methylaminolevulinate photodynamic therapy
2 Recruiting Study Comparing GDC 695 and Diclofenac Sodium Gel, 3% in Subjects With Actinic Keratoses
Condition: Actinic Keratosis
Interventions: Drug: GDC 695;   Drug: Diclofenac Sodium Gel, 3%;   Drug: Vehicle gel
3 Recruiting Efficacy and Safety Phase II Study of SR-T100 to Treat Actinic Keratosis
Condition: Actinic Keratosis
Interventions: Drug: Vehicle gel;   Drug: SR-T100 with 2.3% of SM
4 Recruiting Efficacy and Safety of Treatment of Actinic Keratoses With Photodynamic Therapy Between MAL Cream and ALA Gel
Condition: Actinic Keratosis
Interventions: Drug: METHYLAMINOLEVULINATE HYDROCHLORIDE;   Drug: AMINOLEVULINIC ACID HYDROCHLORIDE
5 Recruiting Daylight Photodynamic Therapy for Actinic Keratosis and Skin Field Cancerization
Condition: Actinic Keratosis
Intervention: Drug: Methyl Aminolevulinate
6 Recruiting Protocols for Painless Photodynamic Therapy (PDT) of Actinic Keratoses
Condition: Actinic Keratosis
Intervention: Procedure: Aminolevulinic acid based photodynamic therapy
7 Not yet recruiting Study of SOR007 Ointment for Actinic Keratosis
Condition: Actinic Keratosis
Interventions: Drug: SOR007 (Uncoated Nanoparticulate Paclitaxel) Ointment;   Other: SOR007 Ointment Vehicle
8 Recruiting Actinic Keratoses Treatment With Metvix® in Combination With Light
Condition: Actinic Keratoses
Interventions: Drug: Metvix®;   Procedure: Photodynamic Therapy Blue light;   Procedure: Photodynamic Therapy Daylight
9 Recruiting Photodynamic Therapy Incubation Times for Actinic Keratosis
Condition: Actinic Keratoses
Interventions: Drug: ALA (5-aminolevulinic acid);   Device: Blue light therapy
10 Not yet recruiting Efficacy of Ingenol Mebutate on Actinic Keratoses and Field Cancerization vs Cryotherapy
Condition: Actinic Keratosis
Interventions: Drug: Ingenol mebutate;   Procedure: cryotherapy
11 Recruiting Multiple-dose Pharmacokinetic Study of Solamargine in Patients With Actinic Keratosis
Condition: Actinic Keratosis
Intervention: Drug: SR-T100 Gel
12 Recruiting Pilot Study of the Pragmatic Use of Mobile Phone Based Follow up of Actinic Keratoses Treated With Topical 5-fluorouracil
Condition: Actinic Keratosis
Intervention: Other: teledermatology feedback
13 Recruiting Ingenol Mebutate Gel 0.05% in Kidney Transplant Recipients With Actinic Keratoses
Condition: Actinic Keratosis
Intervention: Drug: ingenol mebutate 500 ucg
14 Recruiting A Study to Evaluate Two Concentrations of DFD-07 Cream, in Subjects With Actinic Keratosis (AK) of the Face and/or Scalp Over a 12-week Treatment Period
Condition: Actinic Keratosis (AK)
Interventions: Drug: Low dose DFD07 once daily;   Drug: High dose DFD07 once daily;   Drug: High dose DFD07 twice daily;   Drug: Placebo twice daily
15 Recruiting A Randomized, Vehicle-Controlled Study of 2 Concentrations of A-101 for the Treatment of Seborrheic Keratosis
Condition: Seborrheic Keratosis
Intervention: Drug: A-101
16 Not yet recruiting Phase 3 Study of Levulan With New Blue Light for AK on the Face or Scalp
Condition: Actinic Keratosis
Interventions: Drug: ALA;   Drug: Vehicle;   Device: IBL 20 mW;   Device: IBL 10 mW
17 Recruiting Evaluating the Device FLEXITHERALIGHT Compared to the Conventional Photodynamic Therapy
Condition: Keratosis, Actinic
Interventions: Device: FLEXITHERALIGHT PDT;   Device: Aktilite® Galderma
18 Recruiting Evaluation of Non-inferiority and Tolerability of the Device PHOS-ISTOS
Condition: Keratosis, Actinic
Interventions: Device: Aktilite® Galderma;   Device: PHOS ISTOS PDT
19 Recruiting Safety and Efficacy of Ingenol Mebutate Gel 0.015% for Treatment of AK on the Face in Solid Organ Transplant Recipients
Condition: Actinic Keratosis
Intervention: Drug: ingenol mebutate gel 0.015%
20 Not yet recruiting Daylight Photodynamic Therapy for the Treatment of Actinic Keratoses in the Northeast United States
Conditions: Actinic Keratosis;   Non-melanoma Skin Cancer
Intervention: Drug: aminolevulinic acid HCl

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.